Evaluating the socioeconomic burden of pulmonary arterial hypertension on employment and workplace productivity: A Canadian, cross-sectional study

<bold>Introduction:</bold> Pulmonary arterial hypertension (PAH) is a serious condition that commonly affects working-age individuals. This study evaluates the socioeconomic burden of PAH with an emphasis on workplace- and activity-related limitations. <bold>Methods:</bold> We performed a cross-sectional study of symptomatic patients ≥18 years with self-reported Group 1 PAH using surveys distributed between 15-08-2023 and 09-10-2023. Workplace- and activity-related limitations were assessed using the Work Productivity and Activity Impairment questionnaire. Predictors of non-employment were assessed using logistic regression. <bold>Results:</bold> 217 patients were included. Most patients were female (84%) and White (84%) with a median age of 60 years (IQR 46, 68). The majority of patients were self-reported functional class (FC) II (109 patients, 50.2%) or III (73 patients, 33.6%). Of 151 (69.6%) non-employed patients, 76 (50.3%) were retired and 43 (28.5%) reported disability. Of 61 (21.8%) working patients, PAH-related impairment was 42% (SD 29.0%), overall work impairment was 46% (SD 31.6%), and activity impairment was 54% (SD 29.2%). Predictors of employment included younger age, better FC, and being in a living-together relationship (Figure 1). <bold>Conclusion:</bold> Patients with PAH were frequently not employed. Among employed patients, diminished workplace productivity and activity were commonly reported. <fig><object-id>erj;64/suppl_68/PA2498/F1</object-id><object-id>F1</object-id><object-id>F1</object-id><graphic></graphic></fig>

Authors

Institutions

Publication Details

Published
2024-09-14
DOI
https://doi.org/10.1183/13993003.congress-2024.pa2498
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating the socioeconomic burden of pulmonary arterial hypertension on employment and workplace productivity: A Canadian, cross-sectional study

Jason Weatherald, Wendimagegn Alemayehu, Ted Abraham, Cynthia M. Westerhout et al.
Pulmonary Hypertension Research and Treatments
article

Evaluating the socioeconomic burden of pulmonary arterial hypertension on employment and workplace productivity: A Canadian, cross-sectional study

Jason Weatherald, Wendimagegn Alemayehu, Ted Abraham, Cynthia M. Westerhout, Evelyn Budd, Courtney Gubbels, Brandon Budhram, Jamie Myrah
article en

Abstract

<bold>Introduction:</bold> Pulmonary arterial hypertension (PAH) is a serious condition that commonly affects working-age individuals. This study evaluates the socioeconomic burden of PAH with an emphasis on workplace- and activity-related limitations. <bold>Methods:</bold> We performed a cross-sectional study of symptomatic patients ≥18 years with self-reported Group 1 PAH using surveys distributed between 15-08-2023 and 09-10-2023. Workplace- and activity-related limitations were assessed using the Work Productivity and Activity Impairment questionnaire. Predictors of non-employment were assessed using logistic regression. <bold>Results:</bold> 217 patients were included. Most patients were female (84%) and White (84%) with a median age of 60 years (IQR 46, 68). The majority of patients were self-reported functional class (FC) II (109 patients, 50.2%) or III (73 patients, 33.6%). Of 151 (69.6%) non-employed patients, 76 (50.3%) were retired and 43 (28.5%) reported disability. Of 61 (21.8%) working patients, PAH-related impairment was 42% (SD 29.0%), overall work impairment was 46% (SD 31.6%), and activity impairment was 54% (SD 29.2%). Predictors of employment included younger age, better FC, and being in a living-together relationship (Figure 1). <bold>Conclusion:</bold> Patients with PAH were frequently not employed. Among employed patients, diminished workplace productivity and activity were commonly reported. <fig><object-id>erj;64/suppl_68/PA2498/F1</object-id><object-id>F1</object-id><object-id>F1</object-id><graphic></graphic></fig>

University of Calgary (CA), Pulmonary Hypertension Association (US), Merck Canada Inc. (Canada) (CA), Canadian VIGOUR Centre (CA), Pulmonary Associates (US)
Decent work and economic growth
Openalex Percentile: Top 63%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.